<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fujimoto</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Tomioka</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Takakuwa</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Uechi</surname>
    <given-names>GI</given-names>
   </name>
   <name>
    <surname>Yabuta</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Ozaki</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Suyama</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Morimatsu</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Mai</surname>
    <given-names>LQ</given-names>
   </name>
  </person-group>
  <article-title>Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection</article-title>
  <source>J Gen Virol</source>
  <year>2016</year>
  <volume>97</volume>
  <fpage>2104</fpage>
  <lpage>2116</lpage>
  <pub-id pub-id-type="doi">10.1099/jgv.0.000518</pub-id>
  <pub-id pub-id-type="pmid">27260213</pub-id>
 </element-citation>
</ref>
